| Daniel Gaudet | From the Icahn School of Medicine at Mount Sinai, and Regeneron Pharmaceuticals, Department of Internal Medicine and Tygerberg Hospital, Medical University Innsbruck, Austria (C.F.E.) Excel Medical Clinical Trials, Charles E. Schmidt College of Medicine, Florida Atlantic University, Academic Medical Center, Amsterdam (E.S.G.S.) and the Clinical Lipidology and Rare Lipid Disorders Unit, Universite de Montreal Community Gene Medicine Center, and ECOGENE-21 Clinical and Translational Research Center |